Manuka, Inc.
artemis-therapeutics.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q3 FY2023 10-Q, filed Nov 21, 2023. Its latest SEC filing is a REVOKED from Apr 15, 2026.
10-Q for Q3 FY2023, filed Nov 21, 2023
The sections below describe the company as of the FY2022 annual report.
What Did They Do?
Sells skincare products made with Mānuka honey and bee venom to consumers through its website and retail partners.
10-K for FY2022, filed Mar 31, 2023Since its inception, Manuka’s business activities primarily consisted of distributing Mānuka honey imported from New Zealand, developing…View ↗
We currently sell and market our products in Israel through our website, www.bmanuka.co.il. We plan to offer our products on a global basis…View ↗
Our business strategy for commercial sales is intended to be carried out mainly through its online platform and through contracts with…View ↗
Who Were Their Customers?
Consumers buy through the company’s website in Israel. The company also sells through Super-Pharm’s online platform and plans to use health food chains, retail outlets, and online distributors.
10-K for FY2022, filed Mar 31, 2023Manuka was organized under the laws of the State of Israel in March 2020. Manuka is a company with a limited operating history and may…View ↗
We currently sell and market our products in Israel through our website, www.bmanuka.co.il. We plan to offer our products on a global basis…View ↗
Our business strategy for commercial sales is intended to be carried out mainly through its online platform and through contracts with…View ↗
How Were They Changing?
From drug development to skincare
The older report described drug development and said the company had no operating business after its license ended. The latest report describes skincare products made with Mānuka honey and bee venom, sold through an online business.
10-K for FY2019, filed Mar 30, 2020 10-K for FY2022, filed Mar 31, 2023
Who Did They Compete With?
Competes with Manuka Doctor, ApiHealth NZ, Parrs Products, and Abeeco
10-K for FY2022, filed Mar 31, 2023The Mānuka honey and bee venom skincare market is relatively small but is characterized by a rapidly growing pace and intense competition.…View ↗
Loading...
